NACT

基本解释

The NACT group received a chemotherapy with the regiman of CTF(CTX+THP+FUDR)for three cycles before operation.
新輔助化療組術前作3周期CTF(CTX+THP+FUDR)化療,術後補充放療、化療;
The level of serum VEGF decreased significantly in patients who reacted to NACT.
結論：宮頸鱗癌血清VEGF水平明顯陞高；
Neoadjuvant chemotherapy (NACT) has benefitted many and many patients with primary breast cancer.
新輔助化療已經使衆多原發性乳腺癌患者受益。
For patients taking NACT, the levels of serum VEGF were checked before and after the treatment, respectively.
(2)血清VEGF水平與宮頸鱗癌分期、病理分級及淋巴結轉移有關。
To investigate the effect of neoadjuvant chemotherapy (NACT) on the serum VEGF level in advanced cervical squamous carcinoma.
探討VEGF與NACT療傚的相關性，能否作爲新輔助化療療傚的預測指標。